Pharmaceutical composition comprising gaboxadol and an...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/437 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2732636

The present invention relates to a pharmaceutical composition comprising gaboxadol or a pharmaceutically accept-able salt thereof and one or more inhibitors of PAT1 and/or one or more inhibitors of OAT. The present invention further relates to a pharmaceutical composition comprising from about 0.5 mg to about 50 mg gaboxadol or a pharmaceutically acceptable salt thereof, wherein the composition provides an in vivo plasma profile comprising a mean Tmax which is longer than about 20 minutes.

La présente invention concerne une composition pharmaceutique comprenant du gaboxadol ou un sel pharmaceutiquement acceptable de ce dernier ainsi qu'un ou plusieurs inhibiteurs de PAT1 et/ou un ou plusieurs inhibiteurs d'OAT. La présente invention concerne en outre une composition pharmaceutique comprenant entre environ 0,5 mg et environ 50 mg de gaboxadol ou d'un sel pharmaceutiquement acceptable de ce dernier, la composition présentant un profil plasmatique in vivo comprenant un Tmax moyen supérieur à environ 20 minutes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition comprising gaboxadol and an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising gaboxadol and an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising gaboxadol and an... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1708835

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.